Asthma therapies

Moovly Media Inc.
Latest Comments

Valeo Pharma’s rocketing growth in sales points to positive cash flow this year

Stock market investors love companies that can quickly expand and rapidly grow their revenues. The very best of these companies […]

Steve Saviuk of Valeo Pharma on record 2021 revenues, achieving breakeven in 2022, and uplisting on the TSX

In a recent InvestorIntel interview, Tracy Weslosky spoke with Steve Saviuk, CEO of Valeo Pharma Inc. (CSE: VPH | OTCQB: VPHIF) about […]